Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by JE Yun
Prm20 - Clinical Effectiveness and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation: Propensity Weighted Nationwide Cohort Study
British Medical Journal
Medicine
Safety of Once- Or Twice-Daily Dosing of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients With Nonvalvular Atrial Fibrillation: A NOAC-TR Study
Bosnian Journal of Basic Medical Sciences
Medicine
Use of Non-Vitamin K Antagonist Oral Anticoagulants 2008-2016: A Danish Nationwide Cohort Study
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion
Journal of Clinical Trials in Cardiology
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Healthcare Costs of Stroke and Major Bleeding in Patients With Atrial Fibrillation Treated With Non–vitamin K Antagonist Oral Anticoagulants
Journal of Medical Economics
Health Policy
Discontinuation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Population-Based Cohort Study Using Primary Care Data From the Health Improvement Network in the UK
BMJ Open
Medicine
Correction: Discontinuation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Population-Based Cohort Study Using Primary Care Data From the Health Improvement Network in the UK
BMJ Open
Medicine
Risk of Major Bleeding and Stroke Associated With the Use of Vitamin K Antagonists, Nonvitamin K Antagonist Oral Anticoagulants and Aspirin in Patients With Atrial Fibrillation: A Cohort Study
British Journal of Clinical Pharmacology
Pharmacology